TB transmission

NEW YORK, June 14 (Praxis Press) Despite improvements in tuberculosis (TB) control during the past decade, Mycobacterium tuberculosis transmission continues to occur in the United States. Chin and colleagues examined 221 TB case-patients in the San Francisco Bay area and found that seventy-three resulted from one strain of M tuberculosis. Thirty-nine of the 73 case-patients developed TB because they were not identified as contacts of source case-patients; 20 case-patients developed TB because of

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, June 14 (Praxis Press) Despite improvements in tuberculosis (TB) control during the past decade, Mycobacterium tuberculosis transmission continues to occur in the United States. Chin and colleagues examined 221 TB case-patients in the San Francisco Bay area and found that seventy-three resulted from one strain of M tuberculosis. Thirty-nine of the 73 case-patients developed TB because they were not identified as contacts of source case-patients; 20 case-patients developed TB because of delayed diagnosis of their sources; 13 case-patients developed TB because of problems associated with the evaluation or treatment of contacts; and 1 case-patient developed TB because of delay in being elicited as a contact (see paper). Reasons for TB transmission include failure to identify contacts of source case-patients, delayed diagnosis of source case-patients, and problems associated with evaluation or treatment of contacts.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform